Chemed Corporation (CHE) vs Cytokinetics, Incorporated (CYTK)
A side-by-side comparison of Chemed Corporation and Cytokinetics, Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CHE
Chemed Corporation
$509.84HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
CYTK
Cytokinetics, Incorporated
$61.35HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CHE vs CYTK
growth of $100 · dividends reinvested · last 10yCHE +281.4% (+14.3%/yr)CYTK +570.6% (+21.0%/yr)CYTK compounded faster over this window
CHE CYTK
CHE vs CYTK: by the numbers
- •CYTK is the larger company ($7.63B vs $6.66B market cap).
- •CHE is profitable (10.60% net margin) while CYTK runs a net loss (-1259.87%).
- •CHE pays a dividend (0.49% yield), while CYTK has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | CHE | CYTK |
|---|---|---|
| P/E ratio | 25.59 | N/A |
| Forward P/E | 20.00 | N/A |
| P/S ratio | 2.57 | 107.58 |
| P/B ratio | 8.02 | N/A |
| EV / EBITDA | 16.73 | N/A |
| FCF yield | 4.86% | N/A |
Profitability
| Metric | CHE | CYTK |
|---|---|---|
| Gross margin | 30.44% | 84.97% |
| Operating margin | 13.46% | -695.44% |
| Net margin | 10.60% | -1259.87% |
| ROE | 33.11% | N/A |
| ROIC | 19.48% | -39.80% |
Dividends
| Metric | CHE | CYTK |
|---|---|---|
| Dividend yield | 0.49% | N/A |
| Payout ratio | 12.55% | N/A |
Growth (annualized)
| Metric | CHE | CYTK |
|---|---|---|
| Revenue CAGR (5Y) | 4.12% | 4.19% |
| EPS CAGR (5Y) | -1.65% | N/A |
| FCF CAGR (5Y) | -5.44% | N/A |
| Total return CAGR (5Y) | 3.92% | 11.24% |
Frequently asked
- Does CHE or CYTK pay a bigger dividend?
- CHE pays a dividend (0.49% yield), while CYTK has no payments in the available dividend history.
- Is CHE or CYTK more profitable?
- CHE runs the higher net margin — CHE at 10.60% versus CYTK at -1259.87%.
- How have CHE and CYTK total returns compared?
- Over the past 10 years, CHE delivered 14.22% and CYTK delivered 20.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Chemed P/E ratioChemed dividend yieldChemed ROECytokinetics ROEChemed operating marginCytokinetics operating marginChemed revenue growthCytokinetics revenue growthChemed free cash flowCytokinetics free cash flow
Chemed & Cytokinetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.